VBI Vaccines Inc
North American company
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.VBI Vaccines Inc is a biopharmaceutical company. It is engaged in developing novel technologies that seek to expand vaccine protection in large underserved markets.
Latest VBIV News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News